Literature DB >> 10915656

Impact of intrinsic blood flow regulation in cirrhosis: maintenance of hepatic arterial buffer response.

S Richter1, I Mücke, M D Menger, B Vollmar.   

Abstract

The hepatic arterial buffer response (HABR) effectively controls total blood perfusion in normal livers, but little is known about blood flow regulation in cirrhosis. We therefore studied the impact of HABR on blood perfusion of cirrhotic livers in vivo. After 8-wk CCl(4) treatment to induce cirrhosis, 18 anesthetized rats (and 18 noncirrhotic controls) were used to simultaneously assess portal venous and hepatic arterial inflow with miniaturized ultrasonic flow probes. Stepwise hepatic arterial blood flow (HAF) or portal venous blood flow (PVF) reduction was performed. Cirrhotic livers revealed a significantly reduced total hepatic blood flow (12.3 +/- 0.9 ml/min) due to markedly diminished PVF (7.3 +/- 0.8 ml/min) but slightly increased HAF (5.0 +/- 0.6 ml/min) compared with noncirrhotic controls (19.0 +/- 1.6, 15.2 +/- 1.3, and 3.8 +/- 0.4 ml/min). PVF reduction caused a significant HABR, i.e., increase of HAF, in both normal and cirrhotic livers; however, buffer capacity of cirrhotic livers exceeded that of normal livers (P < 0.05) by 1. 7- to 4.5-fold (PVF 80% and 20% of baseline). Persistent PVF reduction for 1, 2, and 6 h demonstrated constant HABR in both groups. Furthermore, HABR could be repetitively provoked, as analyzed by intermittent PVF reduction. HAF reduction did not induce changes of portal flow in either group. Because PVF is reduced in cirrhosis, the maintenance of HAF and the preserved HABR must be considered as a protective effect on overall hepatic circulation, counteracting impaired nutritive blood supply via the portal vein.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10915656     DOI: 10.1152/ajpgi.2000.279.2.G454

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  31 in total

Review 1.  Regulation of hepatic blood flow: the hepatic arterial buffer response revisited.

Authors:  Christian Eipel; Kerstin Abshagen; Brigitte Vollmar
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

2.  A distinct nitric oxide and adenosine A1 receptor dependent hepatic artery vasodilatatory response in the CCl-cirrhotic liver.

Authors:  Alexander Zipprich; Wajahat Z Mehal; Cristina Ripoll; Roberto J Groszmann
Journal:  Liver Int       Date:  2010-05-24       Impact factor: 5.828

3.  Quantitative hepatic perfusion modeling using DCE-MRI with sequential breathholds.

Authors:  Eric M Bultman; Ethan K Brodsky; Debra E Horng; Pablo Irarrazaval; William R Schelman; Walter F Block; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2013-11-04       Impact factor: 4.813

4.  Renal versus splenic maximum slope based perfusion CT modelling in patients with portal-hypertension.

Authors:  Michael A Fischer; Katharina Brehmer; Anders Svensson; Peter Aspelin; Torkel B Brismar
Journal:  Eur Radiol       Date:  2016-02-25       Impact factor: 5.315

5.  Intravoxel incoherent motion diffusion-weighted imaging of hepatocellular carcinoma: Is there a correlation with flow and perfusion metrics obtained with dynamic contrast-enhanced MRI?

Authors:  Stefanie J Hectors; Mathilde Wagner; Cecilia Besa; Octavia Bane; Hadrien A Dyvorne; M Isabel Fiel; Hongfa Zhu; Michael Donovan; Bachir Taouli
Journal:  J Magn Reson Imaging       Date:  2016-02-26       Impact factor: 4.813

Review 6.  Hagen-Poiseuille's law: The link between cirrhosis, liver stiffness, portal hypertension and hepatic decompensation.

Authors:  Gerond Lake-Bakaar; Muneeb Ahmed; Amy Evenson; Alan Bonder; Salomao Faintuch; Vinay Sundaram
Journal:  World J Hepatol       Date:  2015-01-27

7.  Correlation between hepatic blood flow and liver function in alcoholic liver cirrhosis.

Authors:  Hideaki Takahashi; Ryuta Shigefuku; Yoshihito Yoshida; Hiroki Ikeda; Kotaro Matsunaga; Nobuyuki Matsumoto; Chiaki Okuse; Shigeru Sase; Fumio Itoh; Michihiro Suzuki
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

8.  Contrast-enhanced ultrasound for quantitative assessment of portal pressure in canine liver fibrosis.

Authors:  Lin Zhai; Lan-Yan Qiu; Yuan Zu; Yan Yan; Xiao-Zhuan Ren; Jun-Feng Zhao; Yu-Jiang Liu; Ji-Bin Liu; Lin-Xue Qian
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

9.  Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans.

Authors:  Roland H Stimson; Jonas Andersson; Ruth Andrew; Doris N Redhead; Fredrik Karpe; Peter C Hayes; Tommy Olsson; Brian R Walker
Journal:  Diabetes       Date:  2008-10-13       Impact factor: 9.461

Review 10.  Management of Hepatocellular Carcinoma in Cirrhotic Patients with Portal Hypertension: Relevance of Hagen-Poiseuille's Law.

Authors:  Gerond Lake-Bakaar; Muneeb Ahmed; Amy Evenson; Alan Bonder; Salomao Faintuch; Vinay Sundaram
Journal:  Liver Cancer       Date:  2014-10       Impact factor: 11.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.